	US 12,144,891 B2
	Biodegradable drug eluting microsphere for the treatment of solid tumors
Hongxia Zeng, Maple Grove, MN (US); Steven Kangas, Woodbury, MN (US); and Yen-Lane Chen, New Brighton, MN (US)
Assigned to Boston Scientific Scimed, Inc., Maple Grove, MN (US)
Filed by Boston Scientific Scimed, Inc., Maple Grove, MN (US)
Filed on Oct. 9, 2019, as Appl. No. 16/597,122.
Application 16/597,122 is a continuation of application No. 14/986,774, filed on Jan. 4, 2016, granted, now 10,471,012.
Claims priority of provisional application 62/099,719, filed on Jan. 5, 2015.
Prior Publication US 2020/0093745 A1, Mar. 26, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/16 (2006.01); A61K 31/337 (2006.01); A61K 49/00 (2006.01)

CPC A61K 9/1647 (2013.01) [A61K 31/337 (2013.01); A61K 49/0091 (2013.01)]

12 Claims

1. A method of treating a patient, the method comprising: placing, within a blood vessel of a tumor of the patient, polymer microspheres consisting essentially of poly-lactide-co-glycolide 50:50 and 5-10 wt % therapeutic agent such that the blood vessel is embolized.